Biowin Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
as on 12-12-2024
- Paid Up Capital ₹ 2.10 M
as on 12-12-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.43 Cr
as on 12-12-2024
- Revenue -7.49%
(FY 2020)
- Profit 425.02%
(FY 2020)
- Ebitda -156.56%
(FY 2020)
- Net Worth 8.52%
(FY 2020)
- Total Assets 22.06%
(FY 2020)
About Biowin Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹1.43 Cr.
Surendra Mishra, Karunesh Tripathi, Kuwar Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100UP2008PTC035827
- Company No.
035827
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Aug 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biowin Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Mishra  | Director | 12-Aug-2008 | Current |
| Karunesh Tripathi | Director | 12-Aug-2008 | Current |
| Kuwar Singh | Director | 12-Aug-2008 | Current |
| Shashibhooshan Verma | Director | 11-Dec-2023 | Current |
Financial Performance of Biowin Chemicals.
Biowin Chemicals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.49% decrease. The company also saw a substantial improvement in profitability, with a 425.02% increase in profit. The company's net worth moved up by a moderate rise of 8.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biowin Chemicals?
In 2018, Biowin Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biofame Labs Private LimitedActive 14 years 10 monthsSurendra Mishra, Karunesh Tripathi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Oct 2021 | ₹1.10 M | Open |
Others Creation Date: 05 Aug 2020 | ₹2.20 M | Open |
Others Creation Date: 04 Sep 2012 | ₹1.10 Cr | Open |
How Many Employees Work at Biowin Chemicals?
Biowin Chemicals has a workforce of 6 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biowin Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biowin Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
